Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
David R. Cunningham & Cornelius P. Goetzinger. (1974) Extra-High Frequency Hearing Loss and Hyperlipidemia. Audiology 13:6, pages 470-484.
Read now
Read now
Articles from other publishers (33)
H. Greten & G. Schettler. 1983. Therapie innerer Krankheiten. Therapie innerer Krankheiten
382
390
.
S. Marghescu, H. Kather, B. Simon & W. Mohr. 1983. Rheumatologie C. Rheumatologie C
293
336
.
H. Greten & G. Schettler. 1980. Therapie innerer Krankheiten. Therapie innerer Krankheiten
374
382
.
Vazken M. der Kaloustian & Amal K. KurbanVazken M. der Kaloustian & Amal K. Kurban. 1979. Genetic Diseases of the Skin. Genetic Diseases of the Skin
259
289
.
HANS LITHELL, JONAS BOBERG, KRISTOFFER HELLSING, GUDMAR LUNDQVIST & BENGT VESSBY. (2008) Increase of the lipoprotein‐lipase activity in human skeletal muscle during clof ibrate administration. European Journal of Clinical Investigation 8:2, pages 67-74.
Crossref
Crossref
Bill Elliot Cham. (1978) Importance of apolipoproteins in lipid metabolism. Chemico-Biological Interactions 20:3, pages 263-277.
Crossref
Crossref
Russell V. Luepker, L.Kent Smith, Sarah S. Rothchild, Albert Gillis, Leon Kochman & J.Richard Warbasse. (1978) Management of hypercholesterolemia: Evaluation of practical clinical approaches in healthy young adults. The American Journal of Cardiology 41:3, pages 590-596.
Crossref
Crossref
A. Lehtonen & J. Viikari. (2009) Effect of Clofibrate and Calcium in Type II A Hyperlipoproteinaemia. Acta Medica Scandinavica 202:1-6, pages 179-181.
Crossref
Crossref
H. Greten & G. Schettler. 1977. Therapie innerer Krankheiten. Therapie innerer Krankheiten
326
334
.
D. Fedele, A. Tiengo, M. Muggeo, R. Nosadini & G. Crepaldi. (1976) Effects of clofibrate treatment on arginine-induced insulin secretion in endogenous hypertriglyceridemia. Atherosclerosis 25:2-3, pages 191-198.
Crossref
Crossref
C. J. Glueck, S. Ford & R. Fallat. 1976. Fettstoffwechsel. Fettstoffwechsel
353
359
.
G. Schlierf. 1976. Fettstoffwechsel. Fettstoffwechsel
317
351
.
R. I. Levy & G. Assmann. 1976. Fettstoffwechsel. Fettstoffwechsel
301
316
.
R. Fellin, G. Briani, P. Balestrieri, G. Baggio, M.R. Baiocchi & G. Crepaldi. (1975) Long-term effects of colestipol (U-26,597 A) on plasma lipids in familial type II hyperbetalipoproteinaemia. Atherosclerosis 22:3, pages 431-445.
Crossref
Crossref
Ernst-Christian Witte. 1975.
119
192
.
G. Wessels & F. Wessels. 1975. Einundachtzigster Kongress. Einundachtzigster Kongress
1418
1420
.
J. M. Felts & L. L. Rudel. 1975. Hypolipidemic Agents. Hypolipidemic Agents
151
189
.
Peter T. Kuo. (1974) Hyperlipidemia and Coronary Artery Disease: Principles of Diet and Drug Treatment. Medical Clinics of North America 58:2, pages 351-362.
Crossref
Crossref
H. Greten & G. Schettler. 1974. Therapie innerer Krankheiten. Therapie innerer Krankheiten
304
314
.
R.A. Geerdink, P.M. Breel, P.C. Sander & Joke M. Schillhorn-Van Veen. (1973) Comparison of serum cholesterol values in amerindians from surinam with those of dutch controls. Atherosclerosis 18:2, pages 173-178.
Crossref
Crossref
Peter O. KwiterovichJrJr & Simeon Margolis. (1973) Type IV hyperlipoproteinaemia. Clinics in Endocrinology and Metabolism 2:1, pages 41-71.
Crossref
Crossref
H. Greten & G. Schettler. 1973. Therapie innerer Krankheiten. Therapie innerer Krankheiten
304
314
.
Lawrence B. Oscai, Jack A. Patterson, David L. Bogard, Robert J. Beck & Bradley L. Rothermel. (1972) Normalization of serum triglycerides and lipoprotein electrophoretic patterns by exercise. The American Journal of Cardiology 30:7, pages 775-780.
Crossref
Crossref
Neil J. Stone & Robert I. Levy. (1972) The hyperlipidemias and coronary artery disease. Disease-a-Month 18:8, pages 1-35.
Crossref
Crossref
Neil J. Stone & Robert I. Levy. (1972) Hyperlipoproteinemia and coronary heart disease. Progress in Cardiovascular Diseases 14:4, pages 341-359.
Crossref
Crossref
Robert I. Levy & Terry Langer. 1972. Pharmacological Control of Lipid Metabolism. Pharmacological Control of Lipid Metabolism
155
163
.
Robert I. Levy & Terry Langer. (1971) HYPOLIPIDEMIC DRUGS AND HYPERLIPOPROTEINEMIA. Annals of the New York Academy of Sciences 179:1 Drug Metaboli, pages 475-480.
Crossref
Crossref
J.F. Douglas. 1971.
150
161
.
H. Greten. (1971) Clinical aspects of lipid metabolism. Naunyn-Schmiedebergs Archiv f�r Pharmakologie 269:2-4, pages 379-384.
Crossref
Crossref
StefanE. Epstein & HenryG. Schriever. (1970) CREATININE EXCRETION. The Lancet 295:7639, pages 192.
Crossref
Crossref
John Mackay-Dick. (1970) LEECH OUT OF REACH. The Lancet 295:7639, pages 192.
Crossref
Crossref
DonaldS. Fredrickson & RobertI. Levy. (1970) TREATMENT OF ESSENTIAL HYPERLIPIDÆMIA. The Lancet 295:7639, pages 191-192.
Crossref
Crossref
MARGARET IVES, MARIE ZEPPLIN, STANLEY R. AMES, F.M. STRONG & C.A. ELVEHJEM. (1945) The Nutritive Value of Canned Foods: X. Further Studies on Riboflavin, Niacin and Pantothenic Acid1. Journal of the American Dietetic Association 21:6, pages 357-359.
Crossref
Crossref